
National Survey Says Most Americans Willing to Vaccinate Against COVID-19
August 12, 2020 |
Two-thirds or 66 percent of Americans say they are either "somewhat" or "extremely" likely to vaccinate themselves and their children against COVID-19 when such a vaccine becomes available. This is from the results of a recent survey conducted by researchers from four universities conducting, "The COVID-19 Consortium for Understanding the Public's Policy Preferences Across States," which includes Northwestern, Harvard, Northeastern, and Rutgers.
The study, joined by more than 19,000 Americans, found that enthusiasm for a potential COVID-19 vaccine varied greatly across the states. Rates of those describing themselves as "somewhat" or "extremely" likely to vaccinate fell below 60% in 11 states mostly in the South and Mountain West regions, while they exceeded 70% in 11 states across varied regions of the country. The disparity in vaccinations is due to attitudes, not outcomes, according to the report. While 67% of Whites, 71% of Hispanics, and 77% of Asian American respondents say they were likely to vaccinate, just 52% of African-American respondents said the same. Respondents with lower levels of education and lower incomes also said they were less likely to seek a vaccine.
The study also reports that for those likely to vaccinate, 62% identify the need to protect themselves and their families as a motivation, 45% cite protecting people in their community and 59% identify recommendations of medical professionals. Both young adults (18-24) and older adults (65+) more often say they would be likely to be vaccinated, at 71% and 73% respectively, than those ages 25-44 and 45-64 (63% and 64%, respectively).
For more details, read the news article in Northwestern Now.
|
You might also like:
- Most Americans Supportive of Scientific Interventions to Stop COVID-19, 72% Willing to Get Vaccinated
- More Countries Join the COVID-19 Food Coalition
- Study Finds SARS-CoV-2 Has Six Strains
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- FAO: Global Food Prices Rise in July
- Experts Urged to Consider Audience Values when Communicating about Gene Technologies
- Third Breakthrough Shows Photosynthetic Hacks Boost Yield and Conserve Water
- Study Finds Decline in Plant Breeding Programs in the US, Possible Impact on Food Security
- FSANZ Calls for Comments on Food Derived from GM Corn DP202216
-
Research Highlights
- Punjab-wide Survey of Bt Cotton Fields Reveal Variations in Cry Protein Accumulation
- Researchers Decode Black Mustard Seed Genome Using New Sequencing Technology
-
Plant
- Researchers Review Genome Editing Strategies Used in Developing Rice Disease Resistance
- Kansas State University and University of Saskatchewan Team Up to Improve Wheat Using CRISPR
- CRISPR Dominates Genome Editing Market, TALENs Projected to Grow until 2025
-
Health
- National Survey Says Most Americans Willing to Vaccinate Against COVID-19
- Human Immune System Responds to Plant-derived SARS-CoV-2 Antigens
-
Read the latest: - Biotech Updates (February 5, 2025)
- Gene Editing Supplement (January 30, 2025)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet